Researchers have a much more difficult task studying rare cancers because of the lack of samples to compare and work with. However, doing so is necessary and can provide new insights into how things go wrong. Taking a deeper look into chromophobe renal cell carcinoma (ChRCC), a rare kidney cancer, they discovered that it is linked to alterations in genes associated with mitochondria, the energy supplier, telomerase (which controls the life span of cells through division) and in DNA repair. Each of these three changes is related to different symptoms and needs to be treated in their own right. Unlocking why they occur together possibly would provide a key insight into other cancers.
Posted on: Fri, 22 Aug 2014 23:32:06 +0000
Trending Topics
Recently Viewed Topics
© 2015